Filing Details

Accession Number:
0001209191-18-036328
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-07 16:08:37
Reporting Period:
2018-06-05
Accepted Time:
2018-06-07 16:08:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711279 Krystal Biotech Inc. KRYS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298711 Suma Krishnan C/O Krystal Biotech, Inc.
2100 Wharton Street, Suite 701
Pittsburgh PA 15203
Chief Operating Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-05 10,866 $10.75 1,962,328 No 4 P Direct
Common Stock Acquisiton 2018-06-06 13,116 $11.15 1,975,444 No 4 P Direct
Common Stock Acquisiton 2018-06-06 1,018 $12.45 1,976,462 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 112,162 Indirect By trust
Common Stock 2,011,462 Indirect By spouse
Footnotes
  1. This transaction was executed in multiple trades ranging from $10.73 to $11.00. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  2. This transaction was executed in multiple trades ranging from $11.10 to $12.00. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  3. This transaction was executed in multiple trades ranging from $12.11 to $12.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  4. Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
  5. Directly beneficially owned by Krish S. Krishnan, the spouse of the reporting person.